{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Oncology Times: September 2011

Activity Steps

Purpose of Activity

To present registered professional nurses with the latest information about diagnostic and treatment options for prostate cancer.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Outline the evidence presented here about diagnostic options for prostate cancer.
  2. Summarize the latest approaches to treatment of prostate cancer.
Price: $24.95

Credits:

  • ANCC 2.6 CH
  • DC - BON 2.6 CH
  • KY-BON 2.6 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
--------------------------------------------------
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
--------------------------------------------------
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.





Test Code: OT0911
Published: September 10, 2011
Expires: 12/31/2026
Sources: Oncology Times
Required Passing Score: 12/16 (75%)
Authors: Peggy Eastman
Categories: Cancer , Drug Therapy , Oncology
Specialties: Oncology